J
Jishnu Das
Researcher at Ragon Institute of MGH, MIT and Harvard
Publications - 47
Citations - 3421
Jishnu Das is an academic researcher from Ragon Institute of MGH, MIT and Harvard. The author has contributed to research in topics: Vaccination & Interactome. The author has an hindex of 25, co-authored 47 publications receiving 2591 citations. Previous affiliations of Jishnu Das include Cornell University & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
HINT: High-quality protein interactomes and their applications in understanding human disease
Jishnu Das,Haiyuan Yu +1 more
TL;DR: HINT addresses the ubiquitous need of having a repository of high-quality protein-protein interactions and can be utilized to generate specific hypotheses about specific proteins and/or pathways, as well as analyzing global properties of cellular networks.
Journal ArticleDOI
Three-dimensional reconstruction of protein networks provides insight into human genetic disease.
TL;DR: It is found that in-frame mutations are enriched on the interaction interfaces of proteins associated with the corresponding disorders, and that the disease specificity for different mutations of the same gene can be explained by their location within an interface.
Journal ArticleDOI
Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics
Ekta Khurana,Yao Fu,Vincenza Colonna,Vincenza Colonna,Xinmeng Jasmine Mu,Hyun Min Kang,Tuuli Lappalainen,Tuuli Lappalainen,Andrea Sboner,Andrea Sboner,Lucas Lochovsky,Jieming Chen,Arif Harmanci,Jishnu Das,Alexej Abyzov,Suganthi Balasubramanian,Kathryn Beal,Dimple Chakravarty,Danny Challis,Yuan Chen,Declan Clarke,Laura Clarke,Fiona Cunningham,Uday S. Evani,Paul Flicek,Robert Fragoza,Erik Garrison,Richard A. Gibbs,Zeynep H. Gümüş,Javier Herrero,Naoki Kitabayashi,Yong Kong,Kasper Lage,Vaja Liluashvili,Steven M. Lipkin,Daniel G. MacArthur,Daniel G. MacArthur,Gabor T. Marth,Donna M. Muzny,Tune H. Pers,Tune H. Pers,Tune H. Pers,Graham R. S. Ritchie,Jeffrey A. Rosenfeld,Jeffrey A. Rosenfeld,Cristina Sisu,Xiaomu Wei,Michael Wilson,Yali Xue,Fuli Yu,Emmanouil T. Dermitzakis,Emmanouil T. Dermitzakis,Haiyuan Yu,Mark A. Rubin,Chris Tyler-Smith,Mark Gerstein +55 more
TL;DR: In this article, the authors used patterns of polymorphisms in functionally annotated regions in 1092 humans to identify deleterious variants; then, they experimentally validated candidates, finding regions particularly sensitive to mutations and variants that are disruptive because of mechanistic effects on transcription-factor binding.
Journal ArticleDOI
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.
Thomas Hagan,Mario Cortese,Nadine Rouphael,Carolyn M. Boudreau,Caitlin Linde,Mohan S. Maddur,Jishnu Das,Hong Wang,Jenna J. Guthmiller,Nai-Ying Zheng,Min Huang,Amit A. Uphadhyay,Luiz Gustavo Gardinassi,Caroline Petitdemange,Michele Paine McCullough,Sara Jo Johnson,Kiran Gill,Barbara Cervasi,Jun Zou,Alexis Bretin,Megan Hahn,Andrew T. Gewirtz,Steve E. Bosinger,Patrick C. Wilson,Shuzhao Li,Galit Alter,Surender Khurana,Hana Golding,Bali Pulendran +28 more
TL;DR: Antibiotics treatment prior and subsequent to seasonal influenza vaccination revealed significant associations between bacterial species and metabolic phenotypes, highlighting a key role for the microbiome in modulating human immunity.
Journal ArticleDOI
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.
Bronwyn M. Gunn,Wen-Han Yu,Marcus M. Karim,Jennifer M. Brannan,Andrew S. Herbert,Anna Z. Wec,Peter Halfmann,Marnie L. Fusco,Sharon L. Schendel,Karthik Gangavarapu,Tyler B. Krause,Xiangguo Qiu,Shinhua He,Jishnu Das,Jishnu Das,Todd J. Suscovich,Jonathan R. Lai,Kartik Chandran,Larry Zeitlin,James E. Crowe,Douglas A. Lauffenburger,Yoshihiro Kawaoka,Gary P. Kobinger,Kristian G. Andersen,John M. Dye,Erica Ollmann Saphire,Galit Alter +26 more
TL;DR: Antibody-mediated effector functions, including phagocytosis and NK cell activation, were associated with protection, particularly for antibodies with moderate neutralizing activity, and this framework identifies functional correlates that can inform therapeutic and vaccine design strategies against EBOV and other pathogens.